New drug combo trial offers hope for tough pancreatic cancer

NCT ID NCT06821503

Summary

This study is testing a new drug called LM-108, given alongside an immunotherapy drug and two standard chemotherapy drugs, for people with advanced pancreatic cancer that cannot be removed by surgery. The main goals are to see if this combination is safe and if it can help control the cancer and help patients live longer. The trial will enroll about 72 people who have not yet received any treatment for their advanced disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Cancer Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100142, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Cancer Hospital Chinese Academy of Medical Science

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, 100021, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Chongqing Qeneral Hospital

    NOT_YET_RECRUITING

    Chongqing, Chongqing Municipality, 400013, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Harbin Medical University Cancer Hospital

    NOT_YET_RECRUITING

    Harbin, Heilongjiang, 150081, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Huazhong University of Science and Technology Tongji Medical College of Huazhong University of Science and Technology

    NOT_YET_RECRUITING

    Wuhan, Hubei, 430000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Jiangsu Cancer Hospital

    NOT_YET_RECRUITING

    Nanjing, Jiangsu, 210000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Jiangsu Provincial People's Hospital

    NOT_YET_RECRUITING

    Nanjing, Jiangsu, 210000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Peking Union Medical College Hospital

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, 100005, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of China Medical University

    NOT_YET_RECRUITING

    Shenyang, Liaoning, 110000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Nanchang University

    NOT_YET_RECRUITING

    Nanchang, Jiangxi, 330006, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Naval Medical University

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, 200336, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Xi'an Jiaotong University Medical College

    NOT_YET_RECRUITING

    Xi'an, Shaanxi, 710000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Zhengzhou University

    NOT_YET_RECRUITING

    Zhengzhou, Henan, 450000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Sixth People's Hospital of Shenyang

    NOT_YET_RECRUITING

    Shenyang, Liaoning, 110002, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tianjin Cancer Hospital Airport Hospital

    NOT_YET_RECRUITING

    Tianjin, Tianjin Municipality, 300000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tianjin Medical University Cancer Institute & Hospital

    NOT_YET_RECRUITING

    Tianjin, Tianjin Municipality, 300000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.